Maze’s IPO comes on the heels of its oversubscribed Series D funding round, which infused the biotech with $115 million in ...

The U.S. IPO market has seen an uptick amid falling interest rates, strong equity markets, and hopes of a friendlier ...

Cases of acute respiratory illness, Covid-19 and seasonal flu are increasing in most parts of the United States, according to ...

Intensive blood pressure control in patients with chronic kidney disease showed cardiovascular benefits in real-world ...

HealthDay News — Gestational exposure to nonsteroidal anti-inflammatory drugs (NSAIDs) is associated with an increased risk for childhood chronic kidney disease (CHD), although the association is not ...

Smoking increases the likelihood of developing numerous morbidities; however, it remains unclear how this behavior may impact ...

Back pain can often be mistaken for muscle strain or fatigue, but certain types of discomfort could actually point to ...

Alebund Pharmaceuticals ("Alebund" or the "Company"), an integrated biopharmaceutical company focusing on developing innovative therapies for renal diseases and related chronic conditions, announced ...

The live webcast will also be accessible through the “Events” section of the Investor Relations tab within ProKidney’s website at www.prokidney.com. Following the completion of the event, a replay ...

A connection between lung health and kidney function in adults with cystic fibrosis (CF), identifying early urinary markers ...

One tell-tale sign of kidney damage is pain that becomes more pronounced with movements like stretching or twisting. This ...

Kidney transplantation represents a significant advancement for managing end-stage renal disease (ESRD), offering improved recipient quality of life and ...